glp 1 linked to breast cancer A new Penn Medicine study of more than 110,000 women found that those who took GLP-1 medications were about 30% less likely develop than those who did not. Presented Semaglutide decelerates the growth and

Why Understanding This Matters Understanding how these medications work makes it easier to read headlines, navigate medical information and recognise overblown marketing claims

Where is GLP-1 Produced

The global market for GLP-1 weight-loss medications alone was valued at around $13.84 billion in 2024 and is expected to grow at a compound annual growth rate (CAGR) of 18.54%, reaching nearly $48.84 billion by 2030

When blood sugar levels are high, it helps the pancreas release insulin at the right time

Common peroneal neuropathy (CPN) associated with rapid weight loss is attributed to adipose tissue reduction and subsequent nerve compression at the fibular head